德国比伯拉赫/里斯博士后免疫学和呼吸疾病研究

We are seeking a creative and innovative postdoctoral scientist to join the exploratory group within the department of Immunology & Respiratory Diseases Research, to establish new in vitro epithelia-fibroblast co-culture models for fibrotic lung disease research. This is a 2 year post (with potential for 1-2 year extension) that is anticipated to provide new insights into epithelia-fibroblast crosstalk for high-impact publications and to generate new therapeutic concepts. A PhD in Biosciences with a strong background in respiratory, fibrosis or epithelial research is preferred, together with relevant cell culture and assay experience.

Tasks & responsibilities

As a Postdoctoral Fellow you will benefit from a fully resourced and fully funded research environment with access to state-of-the-art tools, technologies and equipment.
You will assume full responsibility for a research project, working closely with a senior research technician and an experienced mentor, and will leverage collaboration opportunities within BI across departments and across sites as well as with academic collaborators.
Embedded in the BI Research organization, you will have regular access to other BI scientists beyond your immediate lab to discuss your science and define the best possible approach at each stage of your project.
You will become part of BI’s international, multi-site Postdoc community, and you will benefit from vibrant scientific discussions with scientists and peers locally as well as globally via using state-of-the-art telecommunication technology and via regular Postdoc retreats.
You will receive sponsorship for attendance of relevant scientific conferences.
You will be expected to publish your scientific results in peer-reviewed journals and present your data at international immunology conferences.
You will be supported by your mentor to define the optimal publication strategy for conference abstracts and actual manuscripts.
Although Postdoc projects are basic science-focused you will gain valuable insights in the drug discovery process via interactions with scientists inside and outside of Boehringer Ingelheim’s Immunology & Respiratory Diseases Research Department

Requirements

PhD in Biosciences with a strong background in respiratory, fibrosis or epithelial research is preferred. PhD candidates who anticipate completion of their PhD thesis within the coming 6 month are also encouraged to apply, as well as MD and PhD candidates
Prior research experience of relevant in vitro experimental techniques/approaches including cell culture primary respiratory epithelial cells and fibroblasts is preferred
Ability to optimise and develop assays/techniques, as well as leverage new technology opportunities, to address scientific questions effectively
Evidence of scientific rigor and excellence in respiratory/fibrosis/epithelial research as documented by relevant peer-reviewed publications
Critical and creative thinking, self-motivated to innovate, and organized
Excellent communication, networking and presentation skills, as well as excellent data analysis and data management skills

About us

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.